BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Australian Diabetes Society - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Australian Diabetes Society
X-ORIGINAL-URL:https://www.diabetessociety.com.au
X-WR-CALDESC:Events for Australian Diabetes Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240515T000000
DTEND;TZID=Australia/Melbourne:20240516T235959
DTSTAMP:20260601T185845
CREATED:20240123T011745Z
LAST-MODIFIED:20240509T062453Z
UID:10000057-1715731200-1715903999@www.diabetessociety.com.au
SUMMARY:Australian Islet Study Group Meeting 2024
DESCRIPTION:The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms\, islet structure and function\, morphology\, in vitro and in vivo models\, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology as it relates to clinical situations including diabetes and challenges in islet transplantation. The AISG Meeting 2024 will take place on Wednesday\, 15th & Thursday\, 16th May 2024 at The Westmead Institute for Medical Research in Westmead\, NSW. \nClick here for the program.\nClick here to register for the event. \nFull registration: A$190.00 (GST included)\nStudent registration: A$90.00 (GST included) \n\nSpeakers \n\n\n\n\n\n\n\n\nKeynote Speaker\nProfessor Lori Sussel\nLori Sussel is the Research Director of the Barbara Davis Diabetes Center (BDC) and Director of the NIDDK-funded University of Colorado Diabetes Research Center. She received her graduate degree from Columbia University Medical School and pursued a postdoctoral fellowship at the University of California\, San Francisco. Her research program involves two major areas of study. One aspect of her research is to understand the biology underlying pancreatic islet cell development and function. These studies have contributed to the ability to grow human islet cells in a dish for cell replacement therapy in type 1 diabetes (T1D). The second aspect of her research is to understand why the immune system targets the insulin producing beta cells within the pancreas with hopes that this knowledge will help prevent disease initiation or protect the beta cells after disease onset. As BDC Research Director\, Professor Sussel has also established an internationally recognised interdisciplinary research division focusing on all aspects of T1D research and discovery.\n\n\n\n\n\n\n\n\n\n \n\nProgram\n \nClick to view the program. \n\n   The ADS gratefully acknowledges the support from Lilly and Sanofi for this educational event.
URL:https://www.diabetessociety.com.au/event/aisg-meeting-2024/
LOCATION:The Westmead Institute for Medical Research\, 176 Hawkesbury Road\, Westmead\, NSW\, 2145\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/01/AISG-2024-Image-e1734915387588.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240527T190000
DTEND;TZID=Australia/Melbourne:20240527T200000
DTSTAMP:20260601T185845
CREATED:20240426T055300Z
LAST-MODIFIED:20240503T055935Z
UID:10000061-1716836400-1716840000@www.diabetessociety.com.au
SUMMARY:Updates from European Renal Association (ERA) Congress 2024 – Outcomes and Clinical Implications of GLP-1 RA in T2DM and CKD
DESCRIPTION:Live Panel Discussion\nThe use of GLP-1 agonists are revolutionising the care of type 2 diabetes and chronic kidney disease. Join us on Monday\, 27 May 2024 from 7:00 pm to 8:00 pm (AEST) as our panel of experts discuss the effects of GLP-1 agonists on renal outcomes. \nWe will be reviewing study results presented at the ERA Congress 2024 and their implications for clinical practice in Australia. \n\nExpert Panel\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nRegistration is free to attend. \nFor any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\n\nThe ADS gratefully acknowledges the support from Novo Nordisk. This is an independent educational event and Novo Nordisk does not have an influence on the program\, speakers or presentations.
URL:https://www.diabetessociety.com.au/event/era-congress-2024-updates/2024-05-27/
LOCATION:VIC
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/04/Webinar-27-May-2024.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
END:VCALENDAR